A case of immune-related adverse events, thyroid dysfunction, myocarditis with myositis, and myasthenia gravis overlap syndrome following serplulimab administration for lung adenocarcinoma
The serplulimab-induced multiorgan irAEs necessitates enhanced monitoring, biomarker research, and multidisciplinary collaboration to optimize safety and antitumor efficacy.
Authors
- Xiaoliang Li
- Pengxi Wang
- Qi Feng
- Dafu Tang
- Yuan Yu
- Hailiang Yu
Institutions
- Sichuan University (CN)
- Fourth People's Hospital of Sichuan Province (CN)
Publication Details
- Journal
- Immunotherapy
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1080/1750743x.2026.2619654
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00